Consolidated Statements of Operations (USD $) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2013		Dec. 31, 2012
Product revenues	$ 27,136		$ 21,674
Service revenues	20,271		8,548
Total revenues	47,407	[1]	30,222	[1]
Cost of sales	16,296		9,319
Gross profit	31,111		20,903
Operating expenses:
Selling, general and administrative	24,836		17,209
Research and development	9,163		7,443
Change in fair value of contingent consideration	4,760
Total operating expenses	38,759		24,652
Operating loss	(7,648)		(3,749)
Interest expense, net	(261)		(28)
Other (loss) income, net	(25)		15
Loss before taxes	(7,934)		(3,762)
Income tax benefit (expense), net	134		(18,539)
Net loss	(7,800)		(22,301)
Less: Net income attributable to non-controlling interests	39
Net loss attributable to ChyronHego shareholders	$ (7,839)		$ (22,301)
Net loss per share attributable to ChyronHego shareholders - basic (in Dollars per share)	$ (0.31)		$ (1.31)
Net loss per share attributable to ChyronHego shareholders - diluted (in Dollars per share)	$ (0.31)		$ (1.31)
Weighted average shares outstanding:
Basic (in Shares)	25,379		16,961
Diluted (in Shares)	25,379		16,961

[1] Included in North America revenues are $25.1 million of revenues from external customers in the United States and included in EMEA revenues are $7.8 million of revenues from external customers in Sweden. No revenues from any other individual country makes up more than 10% of consolidated revenues.